Roy Mattathu John, MD
Cardiac Electrophysiology · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: El Camino Health · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. John’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence C172396 · Current
Licensed to practise in California · since 2021 · expires 2027-04-30 · Kerala University, Medical College Thiruvananthapuram.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$160,493
Medicare paid this office $160,493 for 723 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 44 | $34,580 | $786 |
| Long return visit (40+ min) | 72 | $11,035 | $121 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 12 | $10,434 | $803 |
| Long return visit (40+ min) | 45 | $9,218 | $162 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,824 | $435 |
See all 25 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 44 | $34,580 | $786 |
| Long return visit (40+ min) | 72 | $11,035 | $121 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 12 | $10,434 | $803 |
| Long return visit (40+ min) | 45 | $9,218 | $162 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,824 | $435 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 26 | $7,634 | $254 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $7,424 | $675 |
| New patient visit (60+ min) | 44 | $6,852 | $156 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 19 | $5,862 | $255 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 40 | $4,608 | $115 |
| New patient visit (45+ min) | 28 | $4,365 | $156 |
| New patient visit (60+ min) | 19 | $3,700 | $195 |
| New patient visit (45+ min) | 31 | $3,679 | $119 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 351 | $2,969 | $7 |
| Return visit (30+ min) | 25 | $2,064 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 22 | $2,049 | $71 |
| Return visit (30+ min) | 13 | $1,645 | $118 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 70 | $1,595 | $22 |
| Hospital discharge day management, more than 30 minutes | 13 | $1,469 | $105 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 15 | $1,013 | $63 |
| Programming of dual lead pacemaker system | 22 | $931 | $32 |
| Programming of multiple lead implantable defibrillator system | 11 | $925 | $54 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $909 | $61 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 18 | $189 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $155 | $14 |
Procedures Medicare counted
| Pacemaker insertion or repair | 35 | More than 82% of doctors who do this |
Who their Medicare patients are
723 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 15% · Women 51% · Also on Medicaid 27% · Health risk score 1.88. Above the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 1.8.
Conditions among them: High blood pressure 75% · Atrial fibrillation 60% · Coronary heart disease 50% · Heart failure 44% · Chronic kidney disease 39% · Diabetes 37% · Depression 24% · Cancer 20% · COPD 18% · Stroke 17% · Dementia 15%.
The office billed $1,211,015, Medicare allowed $205,315 and paid $160,493; for 1,263 services of 67 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 723 | 1,263 | 75 | 1.88 | $1,211,015 | $160,493 |
| 2023 | 743 | 1,273 | 74 | 2.28 | $1,016,991 | $140,299 |
| 2022 | 591 | 1,059 | 75 | 2.13 | $807,201 | $118,464 |
| 2021 | 560 | 1,617 | 76 | 2.19 | $864,527 | $162,856 |
| 2020 | 821 | 2,041 | 78 | 2.38 | $1,078,662 | $194,186 |
| 2019 | 663 | 1,330 | 76 | 2.28 | $788,436 | $141,606 |
| 2018 | 186 | 653 | 72 | 2.17 | $601,772 | $115,430 |
| 2017 | 361 | 837 | 73 | 1.74 | $796,665 | $157,896 |
| 2016 | 516 | 1,565 | 73 | 1.66 | $1,351,681 | $260,484 |
| 2015 | 440 | 1,258 | 73 | 1.64 | $1,054,020 | $212,201 |
| 2014 | 414 | 1,295 | 73 | 1.69 | $1,058,046 | $215,892 |
| 2013 | 413 | 1,230 | 73 | 1.75 | $996,584 | $197,248 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 31 | $25,616 | $826 |
| Long return visit (40+ min) | 93 | $13,138 | $121 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $8,755 | $730 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,039 | $423 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 25 | $7,770 | $268 |
| Long return visit (40+ min) | 23 | $4,563 | $163 |
| New patient visit (45+ min) | 44 | $4,159 | $95 |
| New patient visit (60+ min) | 25 | $4,002 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 31 | $3,828 | $116 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 386 | $3,391 | $7 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,210 | $73 |
| Return visit (30+ min) | 40 | $2,891 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 15 | $2,304 | $110 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 78 | $1,986 | $24 |
| Insertion of tube in left heart chamber through heart septum | 11 | $1,985 | $180 |
| Programming of heart rhythm stimulation after drug infusion | 18 | $1,441 | $80 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,392 | $107 |
| Programming of dual lead pacemaker system | 28 | $1,007 | $32 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 12 | $983 | $76 |
| Programming of multiple lead implantable defibrillator system | 14 | $854 | $50 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 12 | $834 | $69 |
2022: 15 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 21 | $20,512 | $977 |
| Long return visit (40+ min) | 73 | $9,940 | $127 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 13 | $9,482 | $729 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 19 | $8,165 | $430 |
| New patient visit (45+ min) | 63 | $7,392 | $117 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 22 | $6,526 | $272 |
| Return visit (30+ min) | 51 | $5,506 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 316 | $2,820 | $7 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 17 | $1,623 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,491 | $65 |
| Programming of dual lead pacemaker system | 37 | $1,442 | $34 |
| New patient visit (30+ min) | 20 | $1,432 | $72 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 50 | $1,241 | $25 |
| Programming of multiple lead implantable defibrillator system | 13 | $974 | $54 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 20 | $582 | $28 |
2021: 26 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 16 | $18,943 | $1,184 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 32 | $16,884 | $512 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 13 | $15,834 | $1,218 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 11 | $10,009 | $910 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 25 | $8,396 | $323 |
| Short return visit (20+ min) | 58 | $7,078 | $83 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 12 | $6,945 | $463 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 56 | $6,031 | $69 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 46 | $6,014 | $131 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 100 | $5,057 | $25 |
| Programming of dual lead pacemaker system | 41 | $4,880 | $71 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 73 | $4,199 | $28 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 258 | $2,750 | $8 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $2,510 | $109 |
| Return visit (30+ min) | 18 | $2,371 | $119 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $2,293 | $191 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,042 | $102 |
| Programming of heart rhythm stimulation after drug infusion | 14 | $1,845 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 91 | $1,829 | $14 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 27 | $1,802 | $35 |
| New patient visit (45+ min) | 11 | $1,395 | $127 |
| New patient visit (30+ min) | 11 | $1,222 | $111 |
| Programming of single lead pacemaker system | 12 | $748 | $58 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 17 | $401 | $24 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 17 | $389 | $23 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $275 | $25 |
2020: 26 services
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 112 | $31,981 | $216 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 12 | $16,300 | $1,164 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 27 | $14,518 | $538 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $13,382 | $1,217 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 15 | $13,093 | $873 |
| Insertion of implantable defibrillator system | 11 | $10,289 | $935 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 24 | $7,720 | $322 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 192 | $6,599 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 138 | $5,478 | $28 |
| Return visit (30+ min) | 36 | $5,303 | $100 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 11 | $5,099 | $464 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,386 | $133 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 385 | $4,290 | $8 |
| Programming of dual lead pacemaker system | 41 | $4,005 | $66 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 112 | $3,803 | $26 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 23 | $3,344 | $134 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 57 | $2,983 | $34 |
| Insertion of tube in left heart chamber through heart septum | 11 | $2,925 | $225 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $2,501 | $167 |
| Programming of multiple lead implantable defibrillator system | 13 | $2,480 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 58 | $1,349 | $16 |
| New patient visit (30+ min) | 12 | $1,255 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,169 | $69 |
| Short return visit (20+ min) | 14 | $1,144 | $71 |
| External ekg recording for more than 48 hours up to 21 days | 17 | $504 | $30 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $416 | $24 |
2019: 19 services
| Insertion of pacemaker and upper and lower heart chamber electrode | 41 | $19,784 | $483 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 17 | $19,094 | $1,061 |
| Insertion of implantable defibrillator system | 15 | $11,278 | $752 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 12 | $9,093 | $758 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 13 | $5,325 | $410 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 441 | $5,072 | $8 |
| Programming of heart rhythm stimulation after drug infusion | 29 | $4,174 | $144 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 17 | $4,167 | $245 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,727 | $124 |
| Return visit (30+ min) | 31 | $2,725 | $83 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 19 | $2,351 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,827 | $65 |
| New patient visit (30+ min) | 17 | $1,675 | $99 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 14 | $1,491 | $99 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,205 | $86 |
| Programming of dual lead pacemaker system | 17 | $1,176 | $56 |
| Short return visit (20+ min) | 16 | $896 | $56 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 45 | $837 | $15 |
| Return visit (30+ min) | 15 | $799 | $47 |
2018: 23 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 18 | $14,880 | $783 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 11 | $10,047 | $837 |
| Insertion of implantable defibrillator system | 14 | $9,448 | $675 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 19 | $7,616 | $305 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 22 | $7,546 | $343 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 19 | $5,521 | $240 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $5,256 | $350 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 32 | $3,861 | $107 |
| Programming of heart rhythm stimulation after drug infusion | 29 | $3,459 | $119 |
| Return visit (30+ min) | 34 | $3,451 | $73 |
| Insertion of tube in left heart chamber through heart septum | 18 | $2,970 | $148 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,998 | $154 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 18 | $1,671 | $84 |
| Return visit (30+ min) | 22 | $1,468 | $56 |
| New patient visit (45+ min) | 13 | $1,426 | $110 |
| New patient visit (45+ min) | 15 | $1,409 | $94 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,373 | $76 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator at time of implantation or replacement | 17 | $1,345 | $79 |
| Short return visit (20+ min) | 22 | $1,250 | $50 |
| Short return visit (20+ min) | 17 | $816 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $663 | $55 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 11 | $415 | $28 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 13 | $374 | $21 |
2017: 23 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 27 | $25,892 | $925 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 16 | $14,724 | $866 |
| Insertion of implantable defibrillator system | 20 | $14,591 | $730 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 35 | $11,867 | $330 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 25 | $9,202 | $368 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 20 | $7,083 | $354 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 18 | $6,835 | $380 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 17 | $6,382 | $336 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 49 | $6,024 | $118 |
| Programming of heart rhythm stimulation after drug infusion | 26 | $3,518 | $130 |
| Insertion of tube in left heart chamber through heart septum | 17 | $2,977 | $165 |
| New patient visit (45+ min) | 22 | $2,097 | $95 |
| Short return visit (20+ min) | 53 | $1,879 | $32 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 11 | $1,100 | $100 |
| Return visit (30+ min) | 13 | $959 | $74 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $902 | $56 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 38 | $740 | $19 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 36 | $685 | $19 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 98 | $676 | $6 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 22 | $395 | $18 |
| Programming of dual lead pacemaker system | 12 | $378 | $31 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 15 | $273 | $18 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 12 | $246 | $21 |
2016: 26 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 62 | $58,760 | $918 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 80 | $27,449 | $323 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 49 | $17,216 | $344 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 22 | $16,254 | $677 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 16 | $15,598 | $918 |
| Insertion of implantable defibrillator system | 19 | $13,840 | $728 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 30 | $11,603 | $387 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 87 | $11,087 | $119 |
| New patient visit (45+ min) | 87 | $8,579 | $99 |
| Programming of heart rhythm stimulation after drug infusion | 52 | $7,215 | $129 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 20 | $6,655 | $333 |
| Short return visit (20+ min) | 133 | $6,440 | $38 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 14 | $5,317 | $380 |
| Insertion of tube in left heart chamber through heart septum | 17 | $3,224 | $170 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 20 | $2,093 | $95 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 220 | $1,891 | $6 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $1,663 | $26 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $1,612 | $49 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 56 | $1,201 | $21 |
| Return visit (30+ min) | 19 | $1,140 | $60 |
| Programming of dual lead pacemaker system | 35 | $1,119 | $27 |
| New patient visit (30+ min) | 13 | $753 | $58 |
| Programming of multiple lead implantable defibrillator system | 13 | $704 | $39 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 29 | $626 | $22 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 27 | $588 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 20 | $441 | $22 |
2015: 30 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 41 | $38,658 | $920 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 54 | $18,372 | $322 |
| Insertion of implantable defibrillator system | 23 | $16,949 | $706 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 36 | $14,621 | $406 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 14 | $14,563 | $910 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 20 | $13,460 | $673 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 29 | $10,321 | $344 |
| Removal of defibrillator electrodes through vein | 19 | $9,837 | $518 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 61 | $7,817 | $120 |
| Short return visit (20+ min) | 120 | $6,505 | $39 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $6,075 | $380 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 14 | $4,815 | $344 |
| New patient visit (45+ min) | 34 | $3,517 | $103 |
| Programming of heart rhythm stimulation after drug infusion | 25 | $3,286 | $131 |
| Insertion of tube in left heart chamber through heart septum | 13 | $2,200 | $169 |
| Removal of defibrillator | 18 | $1,813 | $95 |
| Programming of dual lead pacemaker system | 46 | $1,434 | $30 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 158 | $1,396 | $7 |
| Removal of permanent pacemaker pulse generator | 13 | $1,393 | $107 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 59 | $1,278 | $21 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,165 | $83 |
| Return visit (30+ min) | 17 | $1,097 | $65 |
| Programming of dual lead implantable defibrillator system | 18 | $908 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $816 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $780 | $56 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 26 | $591 | $22 |
| Programming of multiple lead implantable defibrillator system | 11 | $574 | $52 |
| Programming of multiple lead pacemaker system | 12 | $486 | $37 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 17 | $377 | $22 |
| Short return visit | 13 | $273 | $19 |
2014: 30 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 37 | $34,723 | $914 |
| Insertion of implantable defibrillator system | 28 | $20,439 | $730 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 55 | $19,161 | $319 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 24 | $17,819 | $685 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 29 | $10,673 | $368 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 11 | $10,038 | $913 |
| Removal of defibrillator electrodes through vein | 17 | $9,129 | $507 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 24 | $8,565 | $343 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 59 | $7,561 | $120 |
| Short return visit (20+ min) | 135 | $7,182 | $38 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 18 | $6,170 | $343 |
| Insertion of catheters for recording and pacing of right heart chambers rhythm and induction of abnormal rhythm | 13 | $6,070 | $467 |
| Removal of dual electrodes from right heart | 12 | $6,031 | $503 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 15 | $5,674 | $378 |
| New patient visit (45+ min) | 51 | $5,230 | $103 |
| Programming of heart rhythm stimulation after drug infusion | 33 | $4,557 | $130 |
| Insertion of tube in left heart chamber through heart septum | 11 | $2,040 | $170 |
| New patient visit (30+ min) | 33 | $2,021 | $61 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,818 | $96 |
| Removal of defibrillator | 16 | $1,599 | $100 |
| Removal of permanent pacemaker pulse generator | 14 | $1,477 | $105 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 166 | $1,476 | $7 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 22 | $1,275 | $49 |
| Programming of dual lead pacemaker system | 32 | $1,152 | $30 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 46 | $960 | $21 |
| Programming of multiple lead implantable defibrillator system | 13 | $852 | $50 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $502 | $23 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 24 | $476 | $20 |
| Short return visit | 23 | $455 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 19 | $410 | $22 |
2013: 29 services
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $31,569 | $877 |
| Insertion of implantable defibrillator system | 35 | $25,702 | $734 |
| Insertion of tube for 3d mapping of electrical impulses to heart muscle | 51 | $15,662 | $307 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of upper chamber of heart causing supraventricular tachycardia (rapid heart rate) | 19 | $12,540 | $660 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 30 | $11,285 | $376 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality of lower chamber of heart causing ventricular tachycardia (rapid heart rate) or ventricular ectopy (irregular heartbeat) | 12 | $10,628 | $886 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 27 | $8,861 | $328 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 22 | $7,239 | $329 |
| Removal of defibrillator electrodes through vein | 16 | $6,954 | $435 |
| Ultrasound evaluation of heart blood vessel with review by radiologist | 57 | $6,509 | $114 |
| Short return visit (20+ min) | 115 | $6,473 | $38 |
| Insertion of left lower heart electrode for pacemaker or defibrillator | 17 | $6,188 | $364 |
| Removal of dual electrodes from right heart | 12 | $5,717 | $476 |
| New patient visit (45+ min) | 52 | $5,158 | $99 |
| Programming of heart rhythm stimulation after drug infusion | 15 | $1,873 | $125 |
| Insertion of tube in left heart chamber through heart septum | 11 | $1,807 | $164 |
| Insertion of catheters for recording and pacing of left upper heart chamber rhythm and induction of abnormal rhythm | 17 | $1,572 | $92 |
| Removal of defibrillator | 17 | $1,567 | $92 |
| Removal of permanent pacemaker pulse generator | 13 | $1,344 | $103 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 145 | $1,311 | $6 |
| New patient visit (30+ min) | 20 | $1,228 | $61 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 56 | $1,186 | $21 |
| Programming of dual lead pacemaker system | 32 | $1,125 | $29 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | 50 | $994 | $20 |
| Short return visit | 46 | $988 | $19 |
| Short return visit (20+ min) | 11 | $722 | $56 |
| Programming of dual lead implantable defibrillator system | 12 | $685 | $46 |
| Programming of multiple lead implantable defibrillator system | 12 | $644 | $50 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 15 | $402 | $25 |
Medicaid work
$2,456 in 2024
Medicaid paid $2,456 for 287 billed services this clinician did in 2024, up to 150 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 287 | $2,456 |
| 2024 | 287 | 1 | 150 | $2,456 |
| 2023 | 453 | 3 | 107 | $5,476 |
| 2022 | 313 | 1 | 175 | $2,904 |
| 2021 | 115 | 1 | 21 | $530 |
| 2020 | 230 | 1 | 44 | $1,282 |
| 2019 | 182 | 1 | 31 | $1,014 |
See the largest Medicaid services in earlier years
2023
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 402 | $3,773 |
| Long return visit (40+ min) | 39 | $1,404 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 12 | $299 |
2022
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 313 | $2,904 |
2021
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 115 | $530 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 230 | $1,282 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 182 | $1,014 |
Drugs they prescribed that Part D paid
$306,836
Pharmacies billed $306,836 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 667) in 2024. At or below the middle of the specialty; the typical clinical cardiac electrophysiology clinician is at 0%.
404 generic and 263 brand-name prescriptions · $306,836 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 188 | $220,577 | $1,173 |
| Xarelto | 49 | $41,621 | $849 |
| Flecainide Acetate | 57 | $2,851 | $50 |
| Amiodarone | 43 | $1,548 | $36 |
| Metoprolol | 121 | $1,536 | $13 |
See all 10 drugs
| Eliquis | 188 | $220,577 | $1,173 |
| Xarelto | 49 | $41,621 | $849 |
| Flecainide Acetate | 57 | $2,851 | $50 |
| Amiodarone | 43 | $1,548 | $36 |
| Metoprolol | 121 | $1,536 | $13 |
| Diltiazem 24hr Er (Cd) | 25 | $560 | $22 |
| Metoprolol | 60 | $369 | $6 |
| Carvedilol | 12 | $108 | $9 |
| Losartan | 17 | $82 | $5 |
| Spironolactone | 12 | $35 | $3 |
Year by year
| 2024 | 667 | 142 | 0% (0) | 39% | $306,836 |
| 2023 | 450 | 110 | 0% (0) | 49% | $254,382 |
| 2022 | 247 | 67 | 0% (0) | 39% | $110,423 |
| 2021 | 81 | 28 | 0% (0) | 28% | $22,543 |
| 2020 | 61 | 27 | 0% (0) | 18% | $4,615 |
| 2019 | 205 | 47 | 0% (0) | 18% | $29,803 |
| 2018 | 216 | 49 | None | 19% | $31,146 |
| 2017 | 117 | 39 | None | 28% | $17,176 |
| 2016 | 165 | 46 | 0% (0) | 34% | $22,719 |
| 2015 | 108 | 33 | 0% (0) | 27% | $9,895 |
| 2014 | 111 | 35 | 0% (0) | 43% | $14,543 |
| 2013 | 87 | 29 | 0% (0) | 37% | $9,588 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Eliquis | 166 | $178,424 | $1,075 |
| Xarelto | 34 | $42,741 | $1,257 |
| Amiodarone | 26 | $1,757 | $68 |
| Flecainide Acetate | 39 | $1,756 | $45 |
| Metoprolol | 61 | $1,167 | $19 |
| Metoprolol | 38 | $273 | $7 |
2022: 6 drugs
| Eliquis | 73 | $83,237 | $1,140 |
| Dofetilide | 11 | $2,889 | $263 |
| Flecainide Acetate | 23 | $1,630 | $71 |
| Amiodarone | 25 | $1,061 | $42 |
| Metoprolol | 49 | $821 | $17 |
| Metoprolol | 15 | $179 | $12 |
2021: 3 drugs
| Eliquis | 17 | $12,194 | $717 |
| Metoprolol | 15 | $1,181 | $79 |
| Metoprolol | 21 | $763 | $36 |
2020: 1 drug
| Metoprolol | 14 | $407 | $29 |
2019: 6 drugs
| Eliquis | 27 | $21,552 | $798 |
| Sotalol | 13 | $1,406 | $108 |
| Metoprolol | 33 | $806 | $24 |
| Lisinopril | 12 | $118 | $10 |
| Furosemide | 16 | $67 | $4 |
| Carvedilol | 13 | $66 | $5 |
2018: 8 drugs
| Eliquis | 29 | $22,378 | $772 |
| Flecainide Acetate | 19 | $1,282 | $67 |
| Amiodarone | 28 | $889 | $32 |
| Sotalol | 15 | $798 | $53 |
| Metoprolol | 16 | $240 | $15 |
| Cartia Xt | 15 | $193 | $13 |
| Metoprolol | 18 | $157 | $9 |
| Furosemide | 27 | $48 | $2 |
2017: 4 drugs
| Xarelto | 15 | $6,448 | $430 |
| Flecainide Acetate | 30 | $1,767 | $59 |
| Amiodarone | 12 | $1,055 | $88 |
| Metoprolol | 12 | $513 | $43 |
2016: 4 drugs
| Xarelto | 37 | $13,266 | $359 |
| Eliquis | 12 | $5,958 | $496 |
| Flecainide Acetate | 37 | $1,500 | $41 |
| Metoprolol | 40 | $900 | $22 |
2015: 2 drugs
| Metoprolol | 29 | $748 | $26 |
| Flecainide Acetate | 11 | $531 | $48 |
2014: 3 drugs
| Xarelto | 22 | $6,385 | $290 |
| Pradaxa | 12 | $4,119 | $343 |
| Metoprolol | 27 | $893 | $33 |
2013: 3 drugs
| Metoprolol | 18 | $577 | $32 |
| Flecainide Acetate | 14 | $267 | $19 |
| Atenolol | 11 | $54 | $5 |
Money from drug and device companies
$8,938 in 2025
| 2025 | 4 | 46 | $3,850 | $8,938 |
| 2024 | 3 | 13 | None | $1,576 |
| 2023 | 3 | 43 | $2,750 | $4,266 |
| 2022 | 4 | 41 | $50 | $3,892 |
| 2021 | 6 | 47 | $5,088 | $8,775 |
| 2020 | 4 | 18 | $2,625 | $3,346 |
| 2019 | 4 | 40 | $5,500 | $8,917 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Biosense Webster | Carto 3 | $5,805 | 15 payments
|
| Abbott Laboratories | Aveir | $2,593 | 26 payments
|
| Boston Scientific | Farapulse | $367 | 3 payments
|
| Medtronic | Affera Mapping System | $173 | 2 payments
|
See all 46 published payments
| Biosense Webster | Meals · 2025-12-18 | Nuvision Ice Catheter | $98 |
| Boston Scientific | Meals · 2025-12-18 | Rhythmia Mapping System | $66 |
| Medtronic | Meals · 2025-12-18 | Affera Mapping System | $63 |
| Biosense Webster | Meals · 2025-12-09 | Carto 3 | $9 |
| Medtronic | Meals · 2025-12-05 | Affera Mapping System | $110 |
| Abbott Laboratories | Travel · 2025-11-20 | Aveir | $113 |
| Biosense Webster | Meals · 2025-11-18 | Carto 3 | $19 |
| Biosense Webster | Meals · 2025-11-01 | Carto 3 | $29 |
| Biosense Webster | Travel · 2025-11-01 | Carto 3 | $482 |
| Biosense Webster | Consulting · 2025-10-17 | None | $3,850 |
| Biosense Webster | Travel · 2025-10-17 | None | $146 |
| Biosense Webster | Meals · 2025-10-09 | Carto 3 | $15 |
| Biosense Webster | Meals · 2025-10-07 | Carto 3 | $133 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $17 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $39 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $62 |
| Abbott Laboratories | Meals · 2025-10-07 | Aveir | $91 |
| Abbott Laboratories | Travel · 2025-10-07 | Aveir | $203 |
| Abbott Laboratories | Meals · 2025-10-03 | Ensite Precision | $17 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $499 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $293 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $648 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $33 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $151 |
| Abbott Laboratories | Travel · 2025-09-26 | Aveir | $9 |
| Abbott Laboratories | Meals · 2025-08-12 | Viewmate | $24 |
| Abbott Laboratories | Meals · 2025-08-12 | Ensite | $7 |
| Abbott Laboratories | Meals · 2025-08-12 | Ensite | $26 |
| Biosense Webster | Travel · 2025-08-11 | Carto 3 | $174 |
| Biosense Webster | Travel · 2025-08-08 | Carto 3 | $236 |
| Biosense Webster | Meals · 2025-08-01 | Carto 3 | $56 |
| Biosense Webster | Travel · 2025-07-14 | Carto 3 | $262 |
| Abbott Laboratories | Meals · 2025-07-11 | Aveir | $51 |
| Abbott Laboratories | Meals · 2025-07-09 | Ensite Precision | $18 |
| Biosense Webster | Meals · 2025-06-27 | Carto 3 | $147 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $14 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $9 |
| Abbott Laboratories | Meals · 2025-05-30 | Ensite Precision | $120 |
| Abbott Laboratories | Meals · 2025-04-15 | Aveir | $95 |
| Biosense Webster | Meals · 2025-04-10 | Carto 3 | $150 |
| Abbott Laboratories | Meals · 2025-04-07 | Ensite | $6 |
| Abbott Laboratories | Meals · 2025-04-07 | Ensite | $6 |
| Abbott Laboratories | Meals · 2025-03-25 | Ensite | $22 |
| Abbott Laboratories | Meals · 2025-02-17 | Ensite | $19 |
| Boston Scientific | Meals · 2025-01-16 | Farapulse | $95 |
| Boston Scientific | Travel · 2025-01-16 | Farapulse | $207 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,576
| Boston Scientific | Emblem Mri S-Icd | $1,088 | 6 payments
|
| Abbott Laboratories | Aveir | $402 | 6 payments
|
| Biotronik | Acticor 7 Vr-T Dx | $86 | 1 payment
|
2023: $4,266
| Abbott Laboratories | Accent | $3,779 | 39 payments
|
| Medtronic | Selectsecure | $365 | 3 payments
|
| Boston Scientific | None | $123 | 1 payment
|
2022: $3,892
| Abbott Laboratories | Aveir | $2,041 | 22 payments
|
| Medtronic | Micra | $1,479 | 14 payments
|
| Biosense Webster | Carto 3 | $273 | 3 payments
|
| Boston Scientific | General - Therapies | $99 | 2 payments
|
2021: $8,775
| Abbott Laboratories | Confirm Rx | $7,250 | 23 payments
|
| Boston Scientific | Accolade | $1,327 | 20 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $99 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer Smart System | $53 | 1 payment
|
| Philips Electronics North America | (9272) Glidelight | $32 | 1 payment
|
| Medtronic | Cobalt | $13 | 1 payment
|
2020: $3,346
| Abbott Laboratories | Ensite Cardiac Mapping System | $2,625 | 2 payments
|
| Boston Scientific | Accolade | $462 | 11 payments
|
| Biosense Webster | Carto 3 System | $142 | 2 payments
|
| Medtronic Vascular | Micra | $117 | 3 payments
|
2019: $8,917
| Abbott Laboratories | Ensite Cardiac Mapping System | $6,875 | 17 payments
|
| Boston Scientific | Resonate | $756 | 9 payments
|
| Respicardia | Remede System | $651 | 2 payments
|
| Medtronic Vascular | Advisa | $634 | 6 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1417993528
- Licence
- CA C172396California C172396: Current · expires 2027-04-30
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- TN Q029370
- Taxonomy
- Federal specialty code 207RC0001X (207RC0001X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-06-20
- NPI last updated
- 2024-04-22
- NPI record certified
- 2024-04-22
This is when the NPI record was last certified, not a medical board exam.